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Abstract
Background: The timeliness of detection of a sepsis incidence in progress is a crucial factor in the outcome
for the patient. Machine learning models built from data in electronic health records can be used as an
effective tool for improving this timeliness, but so far the potential for clinical implementations has been
largely limited to studies in intensive care units. This study will employ a richer data set that will expand
the applicability of these models beyond intensive care units. Furthermore, we will circumvent several
important limitations that have been found in the literature: 1) Models are evaluated shortly before sepsis
onset without considering interventions already initiated. 2) Machine learning models are built on a restricted
set of clinical parameters, which are not necessarily measured in all departments. 3) Model performance is
limited by current knowledge of sepsis, as feature interactions and time dependencies are hard-coded into the
model. Methods: In this study, we present a model to overcome these shortcomings using a deep learning
approach on a diverse multicenter data set. We used retrospective data from multiple Danish hospitals over
a seven-year period. Our sepsis detection system is constructed as a combination of a convolutional neural
network and a long short-term memory network. We suggest a retrospective assessment of interventions by
looking at intravenous antibiotics and blood cultures preceding the prediction time. Results: Results show
performance ranging from AUROC 0.856 (3 hours before sepsis onset) to AUROC 0.756 (24 hours before
sepsis onset). Evaluating the clinical utility of the model, we find that a large proportion of septic patients
did not receive antibiotic treatment or blood culture at the time of the sepsis prediction, and the model could
therefore facilitate such interventions at an earlier point in time. Conclusion: We present a deep learning
system for early detection of sepsis that is able to learn characteristics of the key factors and interactions
from the raw event sequence data itself, without relying on a labor-intensive feature extraction work. Our
system outperforms baseline models, such as gradient boosting, which rely on specific data elements and
therefore suffer from many missing values in our dataset.
Keywords: Sepsis, Clinical decision support systems, Machine learning, Medical informatics, Early
diagnosis, Electronic health records
1. Introduction
Sepsis is one of the most common causes of death
globally [1]. The World Health Organization es-
timates that more than six million people die of
sepsis annually, and many of these deaths are pre-
ventable [2]. In the United States, severe sepsis
∗Corresponding author Email: sla@enversion.dk
affects more than 700,000 patients each year at a
cost of more than 20 billion dollars [3, 4]. Early
detection of sepsis has shown to improve patient
outcomes, but it remains a challenging problem in
medicine [5]. Even experienced physicians have dif-
ficulties in detecting sepsis early and accurately,
as the early symptoms associated with sepsis may
also be caused by many other clinical conditions [6].
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Previous studies have shown that machine learning
(ML) models trained from data in individual pa-
tient electronic health records (EHR) may be used
for the early detection of sepsis [7, 8, 9, 10, 11, 12].
The ML models for sepsis detection far exceed the
predictive ability of existing clinical early warning
system scores, such as the National Early Warn-
ing Score (NEWS)[7, 9, 10, 12, 13, 14]. Recently,
Shimabukuro et al. demonstrated several positive
effects with the use of an ML model for sepsis de-
tection in a randomized trial. Usage of the model
led to an in-hospital mortality decrease of 12.4 per-
centage points (p=0.018) and an average length
of stay decrease from 13.0 to 10.3 days (p=0.042)
[12]. However, the current studies have limitations.
First, most studies build their ML models on a lim-
ited set of clinical parameters, such as vital signs,
which must be collected at the hospital department
before the model can be used. Emergency depart-
ments and intensive care units (ICU) often have
guidelines for frequent registration of vital signs,
but this is typically not the case in many medical
and surgical departments. The applicability and
deployment potential of the models is therefore lim-
ited due to the comprehensive data registration re-
quirements that are imposed on the departments
in which the models are to be used. Second, dur-
ing model evaluation, it is customary to report only
receiver operating characteristic (ROC) curves and
the derived area under the ROC curve (AUROC).
This type of evaluation is chosen in spite of claims
that AUROC is purely a measure of predictive abil-
ity and does not measure expected clinical useful-
ness, as it does not take prevalence into account
[15, 16, 17]. AUROC may be misleading when ap-
plied to data sets with a high imbalance between
positive and negative samples, which is often the
case within the field of health science. Addition-
ally, most studies are evaluated by ROC curves at
a fixed time relative to the time of sepsis onset. In
a real clinical setting, the evaluation should start
at the time the patient arrives at the hospital, and
the algorithm should be used for inference multiple
times thereafter. Finally, the clinical utility of the
models is typically not investigated in relation to
potential interventions. As an example, it is not re-
ported whether sepsis treatment has already been
initiated at the time of the early detection.
In this paper we present 1) a scalable deep learn-
ing [18] approach for early sepsis detection on the
heterogeneous data set present outside ICUs. 2) We
suggest a sequence evaluation approach that pro-
vides realistic estimations of model performance. 3)
We evaluate the clinical utility of the model in rela-
tion to early interventions with blood cultures and
antibiotics.
2. Materials and methods
2.1. Data population and data sources
The data included health data on all citizens 18
years or older with residency in one of four Dan-
ish municipalities (Odder, Hedensted, Skanderborg,
and Horsens). We used data from the secondary
health sector in combination with nationwide reg-
isters for the period 2010 to 2017. The data from
the secondary health sector contained information
from the EHR, including biochemistry, medicine,
microbiology, medical imaging, and the patient ad-
ministration system (PAS). The data constituted
raw health events of a sequential nature and were
used in the main features for the ML models, as
described in more detail in Sections 2.4 - 2.5.
Source sys-
tem
Data type
Electronic
Health Record
(Patient
administration
system)
Diagnoses (International classification disease
- 10; ICD-10), procedures (NCSP – the
NOMESCO Classification of Surgical Pro-
cedures), booking information, health con-
tent (structured notes containing physiological
measurements, symptom classifications, check
box data such as smoking and exercise habits)
Electronic
Health Record
(Medication
module)
Dates and times for prescriptions and dispens-
ing together with information on ingredients,
dose, administration routes.
Laboratory
system
Microbiology and blood gas analysis
Medical imag-
ing system
Image descriptions from computed tomogra-
phy, magnetic resonance imaging, ultrasound,
X-ray, positron-emission tomography
National Pa-
tient
Register
Hospital admissions, diagnoses (ICD-10), pro-
cedures (NCSP)
Civil Registra-
tion
System
Patient demographics: age, address, and mar-
ital status.
Table 1: Data sources
The National Patient Register [19] and the Civil
Registration System [20] contain information of a
more contextual type, such as previously registered
diagnoses, procedures, hospital admissions, marital
status, and housing situation. These data were used
to additionally include contextual covariates with
information about comorbidities, age, and marital
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status, which had been registered preceding the cur-
rent admission. Table 1 shows a list of the data
sources that were used in the study. The data
were extracted from the research project “CROSS-
TRACKS”1. Representation of the raw sequential
data for a random patient is shown in Figure 1. The
different data sources are color coded so that events
from the same data source have the same color. For
example, both given and prescribed medications are
colored blue. The circle size indicates how many
events have been observed with the same times-
tamp. The size of a circle scales with the square
root of the number of concurring events. Four cir-
cle examples of 1, 5, 10, and 20 events are shown.
2.2. Inclusion criteria and dataset preparation
The data set was constructed in the following
stepwise manner. First, all relevant hospital con-
tacts were identified from a set of 1,002,450 con-
tacts. From this set, 776,219 outpatient contacts
were removed, leaving 226,231 inpatient contacts
to be considered. Second, 11,262 admissions with
a duration of less than three hours were removed.
Third, admissions to hospital departments where
the overall prevalence of sepsis was less than 2%
(162.740 contacts) were removed in order to limit
the number of false positives, leaving 52,229 con-
tacts in total in the data set). In addition, a sec-
ond data set, called the vital sign data set, was
constructed by removing 49,000 contacts with in-
complete vital sign measurements (systolic blood
pressure, diastolic blood pressure, heart rate, respi-
ratory rate, peripheral capillary oxygen saturation,
and temperature) in the three hours preceding the
label time. The vital sign data set thus included a
total of 3,126 contacts (Figure 2). This was done to
have a data set with the possibility of direct com-
parison between all models.
For both data sets, hospital contacts that led to
sepsis were identified (see section 2.3 below), and
the data were split into two parts: one with sepsis-
positive contacts and one with sepsis-negative con-
tacts. Sepsis-positive contacts were further divided
into training data (80%), validation data (10%),
and test data (10%). The training data were used
to fit the model parameters. The validation data
were used to perform an unbiased evaluation of a
model fit during training, and the test data were
used to provide an unbiased evaluation of the final
1http://www.tvaerspor.dk/
model fit on the training data. In the training data,
the sepsis positive contacts were oversampled by a
factor of ten.
For each sequence, we considered at most five
days of data prior to the label time, such that the
sum of the observation and prediction window was
five days (Figure 1). For the positive sequences, the
label time corresponded to the time the positive la-
bel was obtained (sepsis onset). For the negative
sequences, there was no obvious label time, so we
selected a pseudo-random time during the admis-
sion, excluding the first and last three hours of the
admission. In Figure 1, the observation window
is shown with green and the prediction window is
shown with red. The transition between the two
windows is marked by the prediction time, which
is not static but rather sliding from the beginning
of each sequence to the label time. In this way,
both windows are changing size as the prediction
time shifts forward in real time. The label time
will be referred to as t. Thus, the time three hours
before the label time can be written as t-3 hours.
Only 5,9% of patients in the test data set have a
registration of at least two of the vital sign mea-
surements three hours before the label time. Since
several of the selected evaluation metrics are sensi-
tive to stratification and prevalence, we have cho-
sen to test our models on both the full data set
and the vital sign data set. This allows the models
to be compared directly for this smaller sample of
patients.
2.3. Target definition for the early detection of sep-
sis
After the inclusion of hospital admissions, each
admission underwent a binary classification pro-
cess to denote it as either sepsis-positive or sepsis-
negative. The classification was made based on pa-
tients meeting the gold standard for sepsis, which
is based on the 2001 consensus definition of sepsis.
[21]:
The presence of two or more Systemic Inflam-
matory Response Syndrome (SIRS) criteria paired
with a suspicion of infection”. SIRS criteria are
defined as:
• heart rate > 90 beats/min
• body temperature > 38◦ C or < 36◦ C
• respiratory rate > 20 breaths/min or PaCO2
(alveolar carbon dioxide tension) < 32 mm Hg
3
Observation 
 window
Prediction 
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Label time
Time
Prediction time
Numeric measurements
Boolean measurements
Structured notes
Classification
Objective findings 
Short text notes
Figure 1: A visual example of data for a randomly chosen sepsis patient. The observation window has a green background
while the prediction window has a red background. The transition between the two windows is called the prediction time.
The prediction time is not static, as displayed in this snapshot; instead, it is shifting from the beginning of each sequence to
the label time, as the hospitalization progresses. For the sepsis-positive sequences, the label time corresponded to the time of
sepsis onset. For the negative sequences, the label time was randomly chosen within the admission.
Database
Inpatients only
Database
Inpatients only
Vital sign dataset Full dataset
1.002.4501.002.450
226.231226.231
Admissions to hospital departments where 
the prevalence of sepsis was ≥ 2%
Patients with ≥ 1 observations for each vital 
sign measurement
Admissions to hospital departments where 
the prevalence of sepsis was ≥ 2%
To Classifier
To Classifier
52.22952.229
3.126
Admissions ≥ 3 hoursAdmissions ≥ 3 hours
214.969214.969
Figure 2: Inclusion flow chart Left) inclusion criteria for the
Full dataset. Right) inclusion criteria for the Vital sign data
set.
• white cell count > 12 x 109 cells/L or < 4 x
109 cells/L
A hospital admission was labeled sepsis-positive
if the EHR contained data registration fulfilling
the 2001 consensus sepsis definition during admis-
sion. Otherwise, the hospital admission was labeled
sepsis-negative. Importantly, the fulfillment of the
2001 consensus sepsis definition is an independent
EHR registration that occurs continually during ad-
mission. This registration is in contrast to the regis-
tration of diagnoses, which often relates to the time
of discharge. Hence, in this study, the gold stan-
dard may be fulfilled and registered even though
vital sign measurements have not yet been entered
into the EHR.
2.4. Data representation
In the raw data, each sample represents a given
patient as a time-ordered sequence of EHR events
E = (e1, e2, . . . , eT ), where et is an observed event
ordered by t ∈ 1, . . . , T . Each event consists of
three elements: a time stamp, an event category
(e.g., blood pressure or medication code), and a
value. The time for event et is denoted as t (et),
the category c (et), and the value v (et). For ex-
ample, if the category c (et) is blood pressure, then
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v (et) ∈ R2, as it contains both the systolic and
diastolic measurements. Notice that only for the
sequential neural network model, the detailed or-
dering of events is important. In Figure 1, a visual
example of a time-ordered sequence of EHR events
is given.
The raw event data are transformed through two-
step vectorization of the individual events. The first
step will represent each event et by a very sparse
vector et with an entry for all event-value types that
can be observed across all patients. The size of this
vector will be greater than the number of differ-
ent event categories, as a category may have more
than one measurement (e.g., for the blood pres-
sure event from above, the event vector et will have
two nonzero elements, one for each measurement
in v (et)). In the second step, each vector entry
is further transformed as follows. Categorical fea-
tures are converted into their corresponding one-hot
binary feature vector, numerical features are stan-
dard normalized, and hierarchical features, such as
diagnosis codes, are represented as multi-hot vec-
tors with an entry in each of the present levels of
the diagnosis hierarchy. The resulting vectorization
of a given event et is therefore a very sparse, but
not necessarily one-hot, vector et of size 80,000.
A raw event vector sequence may be partitioned
into intervals of time, where the raw event vectors
are then aggregated within a time interval I. We
will let eI denote the interval aggregation of all et
where t (et) ∈ I. Different aggregation functions are
applied across different elements in the event vec-
tors. Binary (categorical) outcomes, such as pro-
cedure codes, are aggregated to numerical counts,
and numerical measurements, such as blood pres-
sure, are converted to minimum, maximum, and
mean values. Naturally, depending on the degree
of aggregation, the ordering of the events in the en-
tire event sequence is ignored to a greater or lesser
extent.
Similar to the raw event vector, we also construct
a vectorization of the context for a given patient.
That is, meta data, such as demographics and the
patient’s comorbidities prior to the first raw event,
are considered in a model. The context vector is
denoted by c and is, in contrast to the raw event
vectors et, not dependent on the sequence ordering
in the model.
2.5. Data preprocessing and model design
The models in this study were built with an onset
using three different approaches: 1) a classical epi-
demiological approach, where the model includes a
small group of selected and clinically well-founded
features; 2) a more data-driven approach, where all
the available data are used in a slightly aggregated
form to train a non-sequential neural network; and
finally 3) a data-driven approach, where the avail-
able data are used in their sequenced form for the
training of a sequential neural network. The first
two models serve as baseline comparison models.
2.5.1. Gradient boosting
In the simplest baseline model, called GB-Vital,
we replicate a well-known sepsis detection model
from the literature, which has shown excellent re-
sults in a randomized study [12]. The full techni-
cal description of the model can be found in [10].
The explanatory features for this model are con-
structed by considering only six vital-sign events
from the raw EHR event sequences: systolic blood
pressure, diastolic blood pressure, heart rate, respi-
ratory rate, peripheral capillary oxygen saturation,
and temperature. The constructed features highly
aggregate the sequence information, and only lim-
ited ordering information is retained. That is, for
each of the six vital signs, five features are con-
structed to represent the average value for the cur-
rent hour, the prior hour, and the hour prior to
that hour along with the trend value between two
succeeding hours.
Based on these 30 features (five values from each
of the six measurement channels), the GB-Vital
model is constructed as a gradient boosted classi-
fier of decision trees. As in [10], each tree in the
gradient boosting model is limited to split at most
six times, and no more than 1000 trees are aggre-
gated to generate the risk prediction. The model
was trained in Python using the Gradient Boosting
Classifier in the Scikit-learn package.
2.5.2. Multilayer perceptron
In the more advanced baseline model, we con-
structed a standard multilayer feedforward neural
network in the form of a multilayer perceptron
(MLP). The model does not limit data to include
only vital signs. Instead, features were constructed
by aggregating entire event vectors in E across ret-
rospective windows of time, including intervals of 1
hour, 2 hours, 4 hours, 8 hours, 16 hours, and 32
hours preceding the time of the label. Notice that
with this coarse aggregation of events, the ordering
of the events is basically ignored, except for the fact
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that the final feature vector for the model concate-
nates the aggregating event vectors in E across the
different sized windows of time. Finally, to remove
noise and reduce dimensionality, we only consider
features that are present in at least 100 sample se-
quences of the training data, resulting in a reduc-
tion from approximately 100,000 to 5000 distinct
entries in the feature vector for each retrospective
timespan, or approximately 30,000 features in total.
The model structure for the MLP in this study
feeds the 30,000 input units together with the 26
contextual features into two hidden layers of 200
units each, which is then followed by the binary de-
cision. The model was trained to optimize the cross
entropy loss using the Adam optimizer [22] with
mini-batches of size 50, a learning rate of 0.0001,
and a dropout of 30% to prevent overfitting. Keras
2.2.2 with a TensorFlow 1.11 backend was used for
the MLP experiments in this study.
2.5.3. CNN-LSTM
In this model we considered all elements in the
entire event sequence E for a patient. As with
the MLP model, we only considered events that
were present in at least 100 sample sequences of
the training data, resulting in approximately 5000
distinct entries in the event vector representation et
for each event et.
The event sequences are further pre-processed
by 1) a temporal preserving aggregation step, 2)
a gap-filling step, and 3) a context concatenation
step. In the temporal preserving aggregation step,
all event vectors are grouped into five-minute non-
overlapping blocks B ⊆ E such that the maximum
time between two events in each block is five min-
utes. The main reason for this step is to reduce the
number of inputs to the model in order to improve
computational efficiency. However, the temporal
aggregation also has the effect of discarding the or-
der of events within each five-minute block, which
is arguably determined by the order in which the
healthcare professional enters the information into
the EHR rather than by the true order of events
that close in time. The gap-filling step now fills
the sequence with empty event vectors such that
all feature vectors in the sequence are equidistant
in time. In this way, there is a vector for every
five minutes in the sequence, some of which are ag-
gregations of one or more event vectors while the
remainder are empty vectors. The sequence can
therefore be represented as a sparse matrix of shape
N ×K, where N is the number of five-minute vec-
tors in the longest sequence (N =
[
t(eT )−t(e1)
5 minutes
]
) and
K is the number of entries in the event feature vec-
tors (K ≈ 5000). Finally, each of the N aggregated
event vectors was concatenated with the same fixed
context vector such that the final sequence matrix
is of shape N × (K + C), where C is the number
of entries in the context vector (C ≈ 30). Recall
that the context vector contains meta data about
the patient, such as age, gender, and comorbidities.
The intuition for concatenating the contextual data
with every event is that the importance of certain
EHR registrations may be supported by such con-
textual information.
This classifier is structured as a convolutional
neural network (CNN), followed by a recurrent
layer of long short-term memory (LSTM) cells, also
known as a CNN-LSTM model (or sometimes Long-
term Recurrent Convolutional Network) [23]. This
architecture has been shown to learn robust tem-
poral feature representations in the convolutional
layers, which makes it easier for the LSTM layer to
capture temporal dependencies compared to using
the raw inputs [24]. The overall architecture of the
classification model is illustrated in Figure 3. The
model first projects the sparse inputs into dense
1000-dimensional vectors, reducing the dimension-
ality for the following convolutional layer by a fac-
tor of five. With inspiration from Conneau et al.
[25], short-term temporal developments for a pa-
tient are now captured in the model by a stack of
“convolutional blocks”. A convolutional block con-
sists of two one-dimensional ReLU-activated convo-
lutional layers followed by a max-pooling layer. All
convolutional layers have kernels of size 3, a stride
of 1, and zero-padding is used. All max-pooling lay-
ers have a kernel size of 2 and a stride of 2, halving
the temporal width of the input. To ensure that
information across the convolutional blocks obeys
the ordering of the input information without con-
taminating the output with information from the
future, all kernels are causal in the sense that they
only filter input from the current time and the past.
There are five convolutional blocks in the model.
The initial block has a depth of 128 for both of
the convolutional layers in the block, whereas the
convolutional layers in the last four blocks all have
a depth of 64. After the input filters through the
five convolutional blocks, each temporal vector at
the output contains partly overlapping information
from a span of 15 hours and 30 minutes of the orig-
inal input, and the temporal distance between each
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Figure 3: The CNN-LSTM architecture for sepsis classification
vector is 2 hours and 40 minutes. Finally, the model
captures the long-term temporal development of a
patient by allowing the output from the convolu-
tional blocks to feed into an LSTM layer that incre-
mentally builds up a representation of the tempo-
ral inputs and continually predicts an output. The
LSTM layer has 64 units and is initialized with
a random initial state. This layer consists of a
“conventional” LSTM layer with a forget gate, as
defined in [26]. Our experiments have showed that
by adding the convolutional layers in front of the
LSTM, we gain significant improvements in both
efficiency and effectiveness compared to using a sin-
gle stacked LSTM. The final prediction layer is a
softmax layer.
The model was trained on a NVIDIA Tesla
V100 GPU. Convergence was reached after approx-
imately 90 minutes.
2.6. Model evaluation
The models in this study will produce a predic-
tion value for each patient p that reflects the risk
that a hospital admission may end up with sepsis
if not intervened upon. This prediction will be in
the range from zero to one, where the predicted risk
should be higher for those patients at risk of later
developing sepsis compared to those that are not.
The discriminative power of a model with proba-
bilistic predictions is typically evaluated at a range
of decision thresholds pτ ∈ [0; 1] for the binary deci-
sion p > pτ and reported in the form of receiver op-
erating characteristic (ROC) curves, precision recall
(PR) curves, area under ROC (AUROC), or mean
average precision (mAP). We report these measures
to enable easy comparison to existing and future
studies that employ evaluations of this kind.
However, while discrimination is an important
statistical property, it does not properly address
clinical usefulness [15, 16, 17, 27, 28, 29]. For exam-
ple, if a false negative decision causes greater harm
than a false positive decision, a model with high
sensitivity may be preferable to a model with high
specificity and lower sensitivity, although the lat-
ter model might have, say, a higher AUROC. In
general terms, a model is clinically useful if the
use of its decisions for patients leads to a better
ratio between benefits and harms than not using
the model. Grounded in the utility measure from
the field of decision theory, decision curve analysis
(DCA) assesses the clinical usefulness of a predic-
tion model by evaluating the so-called net benefit
(NB) at varying decision thresholds for the model
(see, e.g., [30, 31]). Briefly, the net benefit is defined
in Eq. (1), where a true positive and false positive
are abbreviated as TP and FP, respectively:
NB =
TP count− (FP count · weight factor)
total count
(1)
Here, the weighting factor can be interpreted as
the exchange ratio between the number of false pos-
itives that is acceptable in exchange for one true
positive. This interpretation is important because
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it is informative of how the clinician weights the
harm H of a false sepsis-positive decision over the
benefit B of a true decision, with the rationale be-
ing to start intervention for a patient if the expected
harm compared to the benefit is above the clini-
cian’s preference of exchange ratio H/B. For ex-
ample, a weighting factor of 110 indicates that if the
clinician misses one sepsis patient that could have
been detected by the model, it is valued as being
10 times worse than unnecessarily classifying one
healthy person to be at risk of sepsis.
Although informative for the clinician, the for-
mulation of the weighting factor as a harm–benefit
ratio is not operational for the prediction models.
Fortunately, a monotone one-to-one mapping to the
decision threshold can be established, allowing a
dual representation of the weighting factor as fol-
lows:
weighting factor =
H
B
=
pτ
1− pτ (2)
Given a model’s computed risk prediction values
for all patients, a decision curve in DCA can now
be constructed by evaluating the net benefit for the
binary decisions of opting in p > pτ or not p ≤ pτ to
the intervention across a range of different decision
thresholds – or equivalently, for a range of different
harm–benefit exchange ratios.
With different models to consider - including the
extreme options of never intervening or always in-
tervening – the clinician should favor the model
with the highest net benefit at his personally de-
termined H/B ratio. The curves allow the clinician
to alter this ratio in the context of a given patient
(e.g., in accordance with the patient’s preferences).
See Figure 7c for an example of DCA curves. Fi-
nally, Eq. (2) can now be used to translate the
identified H/B weighting factor into the following
operating decision threshold in the chosen model
pτ =
weighting factor
1 + weighting factor
The attentive reader may have noticed that the
above formulation of DCA exclusively focuses on
the patients for whom an intervention will occur,
as is the case in [30]. For the remaining patients,
their hospital contact will continue as usual and
not be affected by the prediction model. This is a
more conservative evaluation than the formulation
of DCA in [31], where harms and benefits for non-
interventions are also included. However, the latter
DCA formulation is more demanding on the elicita-
tion of the weighting factor to be used in an actual
clinical setting, as it now relies on the clinician’s
ability to state a four-way relation between harms
and benefits. In the following, we will use the for-
mer definition of net benefit in our DCA reporting.
2.6.1. Sequence evaluation with retrospective
assessment of intervention potential
(SERAIP)
The evaluation metrics described in Section 2.6
are generic and do not take into account how the
ML model should be used in practice. If the evalua-
tion is to express clinical utility in relation to usage,
then two important aspects need to be addressed:
• The sepsis onset time when the model will be
used is unknown.
• Potential interventions against sepsis may have
already been initiated when the model will be
used.
Concerning the first aspect: A model can per-
form very well when evaluated close to the onset
of sepsis but at the same time perform critically
bad when evaluated many hours before severe sep-
sis symptoms occur. When the model is used in
a real-time clinical setting, the effect of a positive
prediction will be an intervention that cannot be
withdrawn. This implies that model performance
in early timesteps must be carried through and ac-
counted for when evaluating model performance in
subsequent timesteps. We address the effect of pre-
vious model performance by defining the sequence
prediction at time t, pseqt as the maximum proba-
bility of all predictions until then. That is:
pseqt = max
0≤t≤x
(p) (3)
where p is the output probability, t is the timestep
variable, and x is the timestep corresponding to
the prediction time. In this way, a sepsis-positive
classification will be maintained for the subsequent
timesteps, as the effect of a positive prediction will
be an intervention that cannot be withdrawn.
Concerning the second aspect: Predictions from
an ML model are mostly useful if they can lead to
actions. If interventions against sepsis are already
initiated at the time of prediction, the model will
not create any additional value. Generic evaluation
8
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Prediction window72 hour assessment window
Blood cultureIV Antibiotics 
Prediction time Sepsis onset
Figure 4: Sequence evaluation with retrospective assessment of intervention potential (SERAIP). The figure shows the retro-
spective assessment of interventions looking at intravenous antibiotics and blood cultures preceding the prediction time.
metrics, such as ROC, PR, and DCA, do not mea-
sure the clinical usefulness of early sepsis detection
in relation to potential interventions.
We suggest adding a retrospective assessment of
interventions to the evaluation by looking at intra-
venous antibiotics and blood cultures preceding the
prediction time. We include registrations all the
way back to 72 hours before the prediction time to
ensure that all registrations related to clinical pre-
sumptions on sepsis are captured.
At each timestep this assessment is performed for
all TP predictions, yielding the number of TPs with
intra venous antibiotics and TPs with blood culture
individually and TPs with intravenous antibiotics
or blood culture to get a measure of how many cases
there are with a pseqt above τ at prediction time that
have a sepsis-related intervention. Finally, TP with
no intervention is reported to indicate the potential
for early intervention.
Intravenous antibiotics are identified as intra-
venous medications belonging to either the ATC
J01 (antibacterial agents for systemic use) or ATC
J02 (antimycobacterial agents) subgroups, and
blood cultures are identified through the laboratory
system for microbiology. A visual representation of
this evaluation method named sequence evaluation
with retrospective assessment of intervention poten-
tial (SERAIP) is illustrated in Figure 4
3. Results
In our multi-center dataset, the data complete-
ness of vital sign measurements decreased as a func-
tion of time before sepsis onset (Figure 5). In the
interval from sepsis onset and six hours earlier in
time (t − 6 to t − 0), two or more vital signs were
registered for 100% of the septic patients. By mov-
ing the fixed size interval three hours back, covering
the time from t−9 to t−3, the number decreased to
65%. In the range from 18 hours before sepsis onset
to 12 hours before sepsis onset (t−18 to t−12), the
number was down to 43%. Finally, in the interval
between 24 to 30 hours before sepsis onset (t − 24
to t − 30), only 32% of the patients had registered
two or more vital signs.
Figure 5: Data completeness of vital sign measurements de-
creased as a function of time before sepsis onset
3.1. Gradient Boosting
In Figure 6a and 6b, the ROC and PR curves
from the vital sign test data set data are shown,
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respectively. The GB-Vital model achieved an AU-
ROC of 0.786 and a mAP (mean average precision)
of 0.797 when evaluated three hours before sepsis.
Figure 6c shows the results from the DCA. The NB
of using the GB-Vital model was equal to the NB
of treating all patients in the range of probability
thresholds from 0% to 32%. At thresholds above
32%, the NB of using the GB-Vital model exceeded
both the NB of treating none patients and the NB
of treating all patients.
3.2. Multilayer perceptron
The MLP model achieved an AUROC of 0.764
and a mAP of 0.689 when evaluated three hours be-
fore sepsis in the vital sign data set (Figure 6a and
6b). The NB of using the MLP model was equal to
the NB of treating all patients in the range of prob-
ability thresholds from 0% to 20%. At threshold
values above 45%, the NB of using the MLP model
exceeded both the NB of treating no patients and
the NB of treating all patients.
Results from the full data set are summarized
in Figure 7. Figure 7a and 7b show how AUROC
and mAP change as a function of time before the
labeled onset of sepsis (or not sepsis). The MLP
AUROC scores on the full data set were as follows:
t-15 min: 0.872; t-3 hours: 0.871; t-10 hours: 0.751;
and t-24 hours: 0.619. The highest mAP of 0.578
was achieved at three hours. The mAP dropped
on both sides of this peak (0.395 at t-15 min and
0.318 at t-10 hours) and further decreased to 0.147
at t-24 hours.
The NB of using the MLP model on the full data
set was slightly higher than the NB of treating all
patients in the range of probability thresholds from
0% to 12%. In the range from 12% to 20% and
above 45%, the NB was negative. In the range
from 20% to 45%, the model exceeded both the NB
of treating no patients and the NB of treating all
patients (Figure 7c).
In Figure 7, the calibration curve for the MLP
model is shown (blue line). The plot provides an
indication of whether future predicted probabilities
agree with the observed probabilities. For example,
if we predict a 35% risk of developing sepsis, the ob-
served frequency of sepsis should be approximately
35 out of 100 patients with such a prediction. A
perfectly calibrated model would have a 45 degree
line along the diagonal [32, 33].
3.3. CNN-LSTM
The CNN-LSTM model achieved an AUROC of
0.856 and a mAP of 0.79 when evaluated three
hours before sepsis on the vital sign test data (Fig-
ure 6a and 6b). Results from the full data set
showed that the CNN-LSTM model decreased from
a maximum mAP of 0.531 at t-15 min to 0.407 at
both t-10 and t-24 hours. The CNN-LSTM AU-
ROC scores were as follows: t-15 min: 0.879; t-3
hours: 0.842; t-10 hours: 0.792; and t-24 hours:
0.752. The NB of using the CNN-LSTM model on
the full dataset exceeded both the NB of treating
no patients and the NB of treating all patients in
the range of probabilities from 5% to 60% (Figure
7c). The calibration of the CNN-LSTM model is
shown in Figure 7d (orange line).
3.4. SERAIP
Table 2 shows the results of SERAIP.. The
columns “TP with IV antibiotics”, “TP with blood
culture”, “TP with IV antibiotics or blood culture”
and “TP with no intervention” indicate the poten-
tial for initiating interventions that the clinicians
have not already thought about at the time of pre-
diction. Using the first row of the table as an ex-
ample, the model finds 17% of the positives, cor-
responding to 39 patients. The column “TP with
IV antibiotics” shows that 8 patients out of the 39
true positives were already started with intravenous
antibiotics. The column “TP with blood culture”
shows that 12 out of the 39 patients had already
had a blood culture, and “TP with IV antibiotics
or blood culture” shows that 8 of the 12 patients for
whom intravenous antibiotics had been started had
also had a blood culture. Finally, the last column
“TP with no intervention” shows that 27 of the 39
patients had no intervention initiated at the point
of prediction.
The column ”FP/FP” indicates the relationship
between false positives and true positives and shows
that one can expect 9.28 false alarms for every one
true positive.
4. Discussion
4.1. Results
We have presented an accurate deep learning sys-
tem for early sepsis detection on a multi-center data
set from outside ICUs. We have compared three
different approaches for early detection of sepsis:
a GB-Vital model, based on vital sign features; a
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Figure 6: Results from the vital sign test data set evaluated three hours before sepsis onset: a) ROC curves; b) PR curves; c)
DCA.
            
 + R X U V  S U H F H G L Q J  V H S V L V  R Q V H W
    
    
    
    
    
    
    
 $ 8
 5
 2
 &
MLP
 & 1 1  / 6 7 0
(a)
            
 + R X U V  S U H F H G L Q J  V H S V L V  R Q V H W
   
   
   
   
   
   
 $ Y
 H U
 D J
 H 
 3 U
 H F
 L V
 L R
 Q
MLP
 & 1 1  / 6 7 0
(b)
                       
 7 K U H V K R O G  S U R S D E L O L W \    
    
    
    
    
    
    
    
    
 1
 H W
  %
 H Q
 H I
 L W
MLP
 & 1 1  / 6 7 0
 7 U H D W  D O O
 7 U H D W  Q R Q H
 3 U H Y D O H Q F H p H U I H F W  P R G H O
(c)
                       
 0 H D Q  S U H G L F W H G  Y D O X H
   
   
   
   
   
   
 ) U
 D F
 W L R
 Q 
 R I
  S
 R V
 L W L
 Y H
 V
 & D O L E U D W L R Q  S O R W V    U H O L D E L O L W \  F X U Y H 
 3 H U I H F W O \  F D O L E U D W H G 
MLP
 & 1 1  / 6 7 0
(d)
Figure 7: Results from the full test data set: A) AUROC at different predictions times. B) PR curve at different prediction
times. C) DCA three hours before sepsis onset. D) Calibration curve.
non-sequential MLP model with thousands of fea-
tures, including those used for the GB-Vital model;
and a sequential CNN-LSTM model with an equal
number of features.
The GB-Vital model had reasonable perfor-
mance, with an AUROC of 0.786 three hours be-
fore sepsis onset for patients with registered vital
signs, but it underperforms when compared to the
results of previous studies on early sepsis detection.
Qingqing Mao et al. achieved an AUROC of 0.88
[10] three hours before sepsis onset with a similar
GB-Vital model. Nemati et al. reported an AU-
ROC of 0.85 four hours before sepsis onset with a
Weilbull–Cox proportional hazards model. Futoma
et al. reported AUROCs of 0.86 and 0.78 three and
twelve hours before sepsis onset, respectively, with
a multi-output Gaussian processes model [7]. The
reason for the lower AUROC values in our GB-Vital
model is likely due to the amount of missing values
in our data set. All of the above studies are built
solely on data from ICUs, where vital parameters
are recorded frequently. Recall that in our diverse
data set, only 65% of the sepsis patients had at
least two vital signs measured three hours before
sepsis onset. Qingqing Mao et al. examined the
direct impact of missing values in their GB-Vital
model and found that AUROC decreased from 0.9
to 0.79 when increasing the percentage of missing
values from 0% to 20%. Increasing the percent-
age of missing values even further to 60% yielded
an AUROC of 0.75. The reported AUROC of 0.79
with a missing value rate of 20% is directly com-
parable to our GB-Vital model, which archived an
AUROC of 0.786 three hours before sepsis with a
similar rate of missing values. It is important to
note that when Qingqing Mao et al. created a data
set reminiscent of ours, our results correlate.
These numbers indicate that although the GB-
Vital model performs well on ICU data, it may
not be useful for the early detection of sepsis at
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Department/
Hospital
Evaluated
up until
SEN SPE FP/
TP
TP TN FN FP TP
anti
TP
blood
TP
int
TP no int.
Emergency Dept.
Hosp. 1
t-3 hours 0.17 0.91 9.28 39 3663 197 362 8 12 12 27
t-10 hours 0.13 0.91 14.77 22 3456 151 325 4 7 7 15
t-24 hours 0.11 0.90 18.76 17 2899 132 319 1 2 2 15
Dept. of
Oncology
Hosp. 2
t-3 hours 0.31 0.93 7.25 4 389 9 29 3 1 3 1
t-10 hours 0.40 0.93 7.25 4 372 6 29 2 1 3 1
t-24 hours 0.30 0.93 9.33 3 364 7 28 2 0 2 1
Joint
Emergency Dept.
Hosp. 1
t-3 hours 0.33 0.87 3.00 4 78 8 12 0 1 1 3
t-10 hours 0.09 0.10 1.50 6 1 60 9 0 1 1 5
t-24 hours 0.09 0.14 1.20 5 1 50 6 0 0 0 5
Emergency Dept.
Hosp. 3
t-3 hours 1.00 0.92 5.00 1 55 0 5 0 0 0 1
t-10 hours 1.00 0.86 5.00 1 31 0 5 0 0 0 1
t-24 hours 1.00 0.85 5.00 1 28 0 5 0 0 0 1
Dept. of
Anaesthesiology
Hosp. 1
t-3 hours 0.60 0.66 1.83 6 21 4 11 3 2 3 3
t-10 hours 0.45 0.59 2.20 5 16 6 11 1 1 1 4
t-24 hours 0.56 0.60 2.00 5 15 4 10 0 1 1 4
Dept. of
Hematology
Hosp. 2
t-3 hours 0.36 0.93 5.80 5 398 9 29 3 1 3 2
t-10 hours 0.45 0.93 5.80 5 372 6 29 2 1 3 2
t-24 hours 0.30 0.93 9.33 3 364 7 28 2 0 2 1
Dept. of
gastroin. surgery
Hosp. 2
t-3 hours 0.67 0.63 2.75 4 19 2 11 1 0 1 3
t-10 hours 1.00 0.62 2.75 4 18 0 11 1 0 1 3
t-24 hours 1.00 0.63 2.50 4 17 0 10 1 0 1 3
Dept. of
Anaesthesiology
Hosp. 2
t-3 hours 0.33 0.95 1.00 1 19 2 1 0 0 0 1
t-10 hours 0.50 0.95 1.00 1 19 1 1 0 0 0 1
t-24 hours 0.50 0.95 1.00 1 18 1 1 0 0 0 1
Table 2: Results from the “sequence evaluation with retrospective assessment of intervention potential” on the full test data
set. Area under the receiver operating characteristics (AUROC), false positive (FP), true negative (TN), false negative (FN),
false positive (FP), intravenous (IV), Hospital (Hosp.), gastrointestinal (gastroin.), specificity (SPE) sensitivity (SEN), TP
with IV antibiotics (TP anti), TP with blood culture (TP blood), TP with IV antibiotics or blood culture (TP int.), TP with
no intervention (TP no int.).
a broader scale, where vital parameters are not
recorded as frequently across various hospital de-
partments.
In Figure 7a, it can be seen that the MLP and
CNN-LSTM models had close to equal AUROC
performance at time t-3, and in fact, the MLP
model had a better average precision (Figure 7b)
than the CNN-LSTM model. This was probably
because the DNN model was trained on data three
hours before sepsis onset. In contrast, the CNN-
LSTM model appeared to be more stable when used
at different times relative to sepsis onset, which may
be attributed to the sequential modeling approach.
The CNN-LSTM had higher NB values in the
DCA compared to the MLP model for the full range
of threshold values (Figure 7c). In addition, a
slightly odd NB profile could be observed for the
MLP model in the threshold range from 0.05 to 0.2,
indicating that the model was not well calibrated
in this area and therefore would serve poorly as a
risk-estimation model. This was investigated with
a calibration plot, as shown in Figure 7d. The plot
supported our presumption that the MLP model
was poorly calibrated, as the observed frequency of
sepsis was systematically higher than the predicted
risk of developing sepsis, especially in the probabil-
ity ranges of 0.05–0.2 and 0.6–0.8. The CNN-LSTM
model did not seem to suffer from poor calibration.
4.2. SERAIP
The SERAIP is our attempt to create an “close
to the clinic” evaluation yielding an accurate pic-
ture of how the algorithm could support the clini-
cal work at different departments. SERAIP can be
considered an extension of the real-time validation
suggested by Futoma et al. [7].
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We simulated real-world usage by doing a retro-
spective evaluation, investigating two of the most
important actions that a sepsis detection model
could help initiate. Intravenous antibiotics and
blood culture requisitions has been analyzed in the
period preceding predictions, allowing for better es-
timates of the clinical utility of the model. The
numbers for sensitivity and specificity in Table 2
were calculated using a global probability thresh-
old of 0.1, which was determined from inspection
of ROC and DCA. Optimally, a threshold should
have been chosen per department, as the patient
case mix varies greatly.
Looking at the Emergency department, Hospital
1 the model had a sensitivity of 0.17 three hours be-
fore sepsis, which corresponded to finding 39 true
positives, of which 27 had not received any interven-
tion. Conversely, as many as 362 false positives (at
a specificity of 0.91) must be accepted at a thresh-
old of 0.1. The hematology department (Hospital
2) is an example of a department with a completely
different patient clientele than the emergency de-
partment. Here the model had a sensitivity of 0.45
and a specificity of 0.93 ten hours before sepsis on-
set, which corresponded to 5 true positives and 29
false positives. At the same time, no interventions
were initiated for two of the five true positives. An
important observation from the evaluation was that
the model detected a very high proportion of sepsis
patients in departments in which sepsis is not com-
mon. This was probably because septic patients
differ more from the usual clientele than in, for ex-
ample, emergency departments.
4.3. Limitations
4.3.1. Black box
An important improvement in relation to clinical
acceptance would be to implement supporting ex-
planation methods in the predictions, such as layer-
wise relevance propagation, deep Taylor decompo-
sition, pattern attribution, or other DL explana-
tion approaches [34, 35]. It is easy to imagine that
a model that is more interpretable and supported
by explanations would be more easily accepted in
the clinic. Shickel et al. reached the same conclu-
sion in a recent article reviewing the latest trends in
the use of DL on EHR data [36]. They completed
their review with a warning against downplaying
the importance of interpretability in favor of im-
provements in model performance.
4.3.2. Bias and confounding
As the presented DL models (MLP and CNN-
LSTM) operate in a high dimensional feature space
not limited by domain specialists, it is important to
consider the associated bias issues. In June 2018,
Benjamin Recht and colleagues from UC Berkeley
argued that many DL models may be less gener-
alizable than we have assumed [37]. This claim
was supported a month later by Zech et al., who
showed that their DL models were significantly in-
fluenced by organizational and process-oriented el-
ements [38]. Agniel et al. highlighted similar prob-
lems in a study on EHR data [39]. The authors
found that data regarding the time when the blood
samples were ordered were more important than the
blood test results for predicting three-year survival
[5]. The important message in relation to sepsis de-
tection based on EHR data is twofold: 1) If doctors
or nurses have not measured certain vital signs or
ordered certain blood samples, it will not be possi-
ble for models such as GB-Vital to predict sepsis. In
this case, the CNN-LSTM model could still be used
to estimate whether the patient is developing sepsis.
2) On the other hand, the CNN-LSTM model will
most likely contain an unfortunate bias, which may
be important if process-oriented elements change,
such as new IT-systems or workflows.
4.3.3. Reproducibility
Another limitation of this study is that we do not
test our models on the MIMIC-III database, unlike
several of the studies we compare ourselves to. Due
to the large differences in available data sources, it
did not made sense to test our model on MIMIC-III
data [40]. However, we suggest that our proposed
methods should be tested on MIMIC-III data in the
future.
4.3.4. Case-control matching
In this study, we exclusively sampled our nega-
tive cases from simple naive rules, such as age and
contact length. This means that our data sets po-
tentially contain many patients that our algorithm
could easily categorize as negatives. An improved
sampling technique would be to match sepsis-
positive contacts with ”similar” sepsis-negative
contacts in a case control matching approach, as
suggested in [7]. In that study, the authors imple-
mented a propensity scoring mindset that seemed
to be inspired by causal inference estimation theory.
13
4.3.5. Dataset construction and oversampling
In section 2.2, we described how we oversampled
the positive samples by a factor of 10 and then sam-
pled negatives until we reached a ratio of 1:5. We
explored many different combinations in relation
to sampling techniques and balancing. Undersam-
pling of the negative class worsened the test per-
formance dramatically, indicating poor sampling of
the variation space. Class ratios greater than 1:5
combined with weight-adjusted loss functions also
reduced test performance, as did oversampling fac-
tors greater than ten. It could make sense to try
more sophisticated sampling or data augmentation
techniques to achieve better training performance.
5. Conclusion
In this multi-center retrospective study, we
present a novel deep learning system for early detec-
tion of sepsis in the heterogeneous data set present
outside ICUs. The system learns representations of
the key factors and interactions from the raw event
sequence data itself, without relying on a labor-
intensive feature extraction process. Our study in-
dicates that sequential deep learning models can
be used to detect sepsis at a very early stage, and
we find that our model outperforms strong baseline
models, such as GB-Vital, which rely on specific
data elements and therefore suffer from many miss-
ing values in our data set. We also propose a new
retrospective evaluation technique for assessing the
clinical utility of the model that accounts for both
intravenous antibiotics and blood culture requisi-
tions. The evaluation showed that a large propor-
tion of sepsis patients had not initiated intravenous
antibiotics or blood culture at the time of early de-
tection, and thus the model could facilitate such
interventions at an earlier point in time.
Two interesting directions for future work would
be to add supporting explanation methods into the
predictions to improve clinical acceptance and to
test our models on the MIMIC-III database.
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